These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 658339)

  • 21. [Effect of physical exercise during drug therapy of chronic cholecystoangiocholitis (clinicophysiological study)].
    Ragimov DM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):518-21. PubMed ID: 5515370
    [No Abstract]   [Full Text] [Related]  

  • 22. The condition of the biliary tract and cholesecretion in cases of ulcerative colitis.
    Abasov IT; Isaev EG; Iof IM
    Hepatogastroenterology; 1985 Jun; 32(3):138-40. PubMed ID: 4018708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of xylite on hepatic and pancreatic function in biliary pathology].
    Rafes IuI; Sheleketina II; Voroteliak VS; Kulikova ZS; Mel'nichenko LIa
    Vrach Delo; 1972 Feb; 2():10-4. PubMed ID: 5084716
    [No Abstract]   [Full Text] [Related]  

  • 24. [New therapeutic technic in diseases of the efferent bile ducts].
    Dierel H
    Wien Med Wochenschr; 1972 Apr; 122(14):187-90. PubMed ID: 5014036
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of urolesan and phenicarbaran in the combined treatment of chronic cholecystitis].
    Neĭko EM; Skrobach NV
    Vrach Delo; 1985 Jul; (7):13-6. PubMed ID: 4049815
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trial of an hepatobiliary analeptic agent].
    Chapuy H; Jeune M; Sambin P; Girard M
    J Med Lyon; 1971 Jun; 52(211):1025-34. PubMed ID: 5138331
    [No Abstract]   [Full Text] [Related]  

  • 27. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
    Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
    Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biliary tract function and bile secretion in patients with nonspecific ulcerative colitis].
    Abasov IT; Isaev EG
    Ter Arkh; 1984; 56(2):95-9. PubMed ID: 6710417
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of Cholipin on bile formation and secretion, its therapeutic spectrum].
    Andrejević M; Stanković S
    Med Glas; 1968 Nov; 22(11):389-91. PubMed ID: 5200353
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current status of hepatic and biliary drug therapy. Part I].
    Donatelli L; Marmo E
    Clin Ter; 1976 Mar; 76(5):395-409. PubMed ID: 791566
    [No Abstract]   [Full Text] [Related]  

  • 31. [In process].
    Vollmer H
    Med Monatsschr Pharm; 2017 Mar; 40(3):131. PubMed ID: 29952486
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trial of a hepato-biliary medication].
    Etaix JP
    J Med Lyon; 1969 Feb; 50(158):223-6. PubMed ID: 4181199
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effects of drugs on extrahepatic bile ducts].
    Ritter U
    Med Klin; 1979 Jul; 74(27):1047-52. PubMed ID: 470790
    [No Abstract]   [Full Text] [Related]  

  • 34. [Alpha-(1-hydroxy-4-phenylcyclohexyl)-butyric acid, a synthetic choleretic. Pharmacology, clinical aspects and review considerations on the experience of a few years of systematic use of the choleretic alone or in combination with other substances in hepatocholecystic syndromes].
    Barbi G
    Minerva Gastroenterol; 1966; 12(2):64-7. PubMed ID: 5960468
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: The effect of florantyrone (Zanchol) on the composition of T-tube bile.
    Kirkpatrick JR; Eastwood MA; Mitchell WD
    Gut; 1974 Oct; 15(10):830. PubMed ID: 4434947
    [No Abstract]   [Full Text] [Related]  

  • 36. [A rationale for the use of Carlsbad salt-enriched water in treating patients with biliary tract diseases at a sanatorium].
    Ignatova NZ; Garkavi EG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (6):50-1. PubMed ID: 2534242
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of liver diseases in the hands of the general practitioner].
    Blank K
    Z Allgemeinmed; 1969 Apr; 45(11):525-7. PubMed ID: 5785113
    [No Abstract]   [Full Text] [Related]  

  • 38. [Choleretics: their collateral effects on bile production].
    Clin Ter; 1971 Aug; 58(4):551-62. PubMed ID: 5158279
    [No Abstract]   [Full Text] [Related]  

  • 39. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
    Grossi F; Spada S
    Clin Ter; 1969 Aug; 50(3):203-32. PubMed ID: 5387397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.